Why the study?
Does echocardiographically measured epicardial adipose tissue thickness predict cardiometabolic risk and cardiovascular outcomes?
Does echocardiographically measured epicardial adipose tissue thickness predict cardiometabolic risk and cardiovascular outcomes?
Echocardiographic measurement of epicardial adipose tissue thickness may serve as a useful marker and predictor of cardiometabolic risk.
Answers are grounded in this paper and cite their sources.
Echocardiographic epicardial fat thickness may mark cardiometabolic risk; leaves open routine adoption pending prospective validation.
Background and Purpose: Epicardial fat is the true visceral fat located around the heart, particularly around sub-epicardial coronary arteries that may locally interact and modulate the coronary arteries and myocardium through paracrine or vasocrine secretion of anti-inflammatory and proatherogenic cytokines. Most previous studies have used echocardiography and reported controversial results, probably due to differences in measuring techniques and study population. Materials and Methods: A review of literature was conducted using the PubMed and Google Scholar databases in addition to Google and Yahoo search engines. The purpose was to look for articles describing the association between echocardiographically measured EAT and the major related outcomes including coronary artery disease, left ventricular systolic, diastolic dysfunction, and atrial fibrillation. Finally, 34 articles were included in the results of the present review. Result: The potential role of echocardiographic epicardial fat thickness as a marker and predictor of cardio metabolic risk has been suggested.
No takes yet. Share an insight, caveat, or question.
Maryam Nabati (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: